TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
Ahmed M, Lopez-Albaitero A, Pankov D, Santich BH, Liu H, Yan S, Xiang J, Wang P, Hasan AN, Selvakumar A, O'Reilly RJ, Liu C, Cheung NV.
Ahmed M, et al. Among authors: cheung nv.
JCI Insight. 2018 Feb 22;3(4):e97805. doi: 10.1172/jci.insight.97805. eCollection 2018 Feb 22.
JCI Insight. 2018.
PMID: 29467338
Free PMC article.